The combination of a highly stereoselective tethered olefin metathesis reaction and a Julia−Kocienski olefination is presented as a strategy for the synthesis of conjugated polyenes with at least one Z-configured CC bond. The strategy is exemplified by the synthesis of the marine natural product (+)-bretonin B.
Four combinations of type-I olefins
isoeugenol and 4-hydroxy-3-methoxystyrene
with type-II olefins acrolein and crotonaldehyde were investigated
in cross-metathesis (CM) reactions. While both type-I olefins are
suitable CM partners for this transformation, we observed synthetically
useful conversions only with type-II olefin crotonaldehyde. For economic
reasons, isoeugenol, a cheap xylochemical available from renewable
lignocellulose or from clove oil, is the preferred type-I CM partner.
Nearly quantitative conversions to coniferyl aldehyde by the CM reaction
of isoeugenol and crotonaldehyde can be obtained at ambient temperature
without a solvent or at high substrate concentrations of 2 mol·L–1 with the second-generation Hoveyda–Grubbs
catalyst. Under these conditions, the ratio of reactants can be reduced
to 1:1.5 and catalyst loadings as low as 0.25 mol % are possible.
The high reactivity of the isoeugenol/crotonaldehyde combination in
olefin metathesis reactions was demonstrated by a short synthesis
of the natural product 7-methoxywutaifuranal, which was obtained from
isoeugenol in a 44% yield over five steps. We suggest that the superior
performance of crotonaldehyde in the CM reactions investigated can
be rationalized by “methylene capping”, i.e., the steric
stabilization of the propagating Ru-alkylidene species.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.